Saturday, June 23, 2007

Nor Calif - M'sia Biotech

The QB3-Malaysia Postgraduate and Postdoctoral Training Program

About the Program


The term neglected diseases refers to all human diseases in which there is little or no commercial interest. Western pharmaceutical and diagnostic companies believe that they cannot recover an income from those diseases commensurate with the development costs. In practice, neglected diseases predominantly affect the populations in the developing world. We foresee that diseases neglected by the west can become commercially viable targets for emerging economies like Malaysia, if they can deploy a less expensive but technically sophisticated work force to do development at a cost that moves many diseases out of the neglected category.

With this vision in mind, the Malaysian Biotechnology Corporation has entered into a partnership with the California Institute for Quantitative Biosciences (QB3) to start an exciting new training program to train outstanding Malaysian researchers who will both help developing nations and create biotechnology jobs for Malaysians.

No comments: